Checked
Bionano Genomics, Inc.
Nasdaq: BNGO · Laboratory Analytical Instruments · San Diego, CA
- Revenue
- $28.51M
- -7.4% vs. prior year
- Net income
- -$26.39M
- -92.6% net margin
- Total assets
- $73.58M
- Diluted EPS
- -$4.85
Company details
As reported to the SEC
- SEC CIK
- 1411690
- Stock
- Nasdaq: BNGO
- Legal Entity Identifier (LEI)
- 54930086AP7ROH0VJ631
- Industry (SIC)
- Laboratory Analytical Instruments (3826)
- Headquarters
- 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121
- Incorporated in
- Delaware
- Fiscal year end (SEC record)
- December 31
- Filer status
- Non-accelerated filer, Smaller reporting company
- Phone
- (858) 888-7600
- Employer ID (EIN)
- 26-1756290
- Last annual report
- 03/23/2026
- Last quarterly report
- 08/10/2026
Formerly: BioNano Genomics, Inc (until 10/20/2021); Bionano Genomics, Inc (until 10/20/2021); BioNanomatrix Inc (until 03/24/2011)
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Revenue | $28.51M | $30.78M | $36.12M | $27.8M | $17.98M |
| Operating income | -$33.34M | -$104M | -$215.2M | -$131.7M | -$77.1M |
| Net income | -$26.39M | -$112M | -$232.5M | -$132.6M | -$72.44M |
| Diluted earnings per share | -$4.85 | -$88.13 | -$408.60 | -$4.58 | -$0.26 |
| Research and development | $11.37M | $24.8M | $54.03M | $49.05M | $22.48M |
| Total assets | $73.58M | $76.67M | $214.4M | $307.5M | $377.1M |
| Total liabilities | $29.16M | $41.3M | $118.2M | $58.1M | $39.98M |
| Shareholders' equity | $44.42M | $35.38M | $96.16M | $249.4M | $337.1M |
| Cash and cash equivalents | $2.99M | $9.17M | $17.95M | $5.09M | $24.57M |
| Long-term debt | Not reported | Not reported | Not reported | Not reported | $0 |
| Cash from operations | -$16.34M | -$68.92M | -$125.2M | -$124.8M | -$71.93M |
Federal and state records filed under the name Bionano Genomics, Inc.
Matched by the company name and by the subsidiary names it lists in SEC filings and other public records, after removing endings like Inc., Corp. and Holdings. Records marked Subsidiary were filed under a subsidiary name. A subsidiary that is not listed in those records is not included, and an unrelated business with the same name can appear.
Work visa sponsorship
Certified H-1B and PERM green card filings with the Department of Labor
| Employer on filing | H-1B | PERM |
|---|---|---|
| Bionano Genomics, Inc.San Diego, CA | 0 | 1 |
Subsidiaries
4 companies that Bionano Genomics, Inc. owns or controls, as listed in its SEC annual report (Exhibit 21), GLEIF ownership records or USAspending
| Subsidiary | Listed in |
|---|---|
| BioDiscovery, Inc , a California limited liability company | SEC 10-K |
| Bionano Genomics (Shanghai) Trading Co., Ltd. | SEC 10-K |
| Bionano Genomics UK, Ltd. | SEC 10-K |
| Purigen Biosystems, Inc. , a Delaware corporation | SEC 10-K |
Recent filings
118 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
| Form | Filed | Period |
|---|---|---|
| SCHEDULE 13GOwnership report (5% holder, passive) | 10/19/2026 | None |
| 8-KRegulation FD disclosure | 09/14/2026 | 09/14/2026 |
| SCHEDULE 13G/AOwnership report (5% holder, passive, amended) | 08/14/2026 | None |
| 10-QQuarterly report | 08/10/2026 | 06/30/2026 |
| 8-KResults of operations | 08/10/2026 | 08/10/2026 |
| 8-KOther events | 06/24/2026 | 06/24/2026 |
| 8-KDirector or officer change | 06/05/2026 | 06/02/2026 |
| 8-KOther events | 05/28/2026 | 05/28/2026 |
| 8-KShareholder vote results | 05/14/2026 | 05/14/2026 |
| 10-QQuarterly report | 05/13/2026 | 03/31/2026 |
| 8-KResults of operations | 05/13/2026 | 05/13/2026 |
| S-3Shelf registration statement | 05/08/2026 | None |
| 8-KDirector or officer change, Other events | 05/06/2026 | 05/05/2026 |
| ARSAnnual report to shareholders | 04/02/2026 | 12/31/2025 |
| DEFA14AAdditional proxy materials | 04/02/2026 | None |
| DEF 14AProxy statement | 04/02/2026 | 04/01/2026 |
| S-8Registration of employee stock plan shares | 03/25/2026 | None |
| 10-KAnnual report | 03/23/2026 | 12/31/2025 |
| 8-KResults of operations | 03/23/2026 | 03/23/2026 |
| SCHEDULE 13G/AOwnership report (5% holder, passive, amended) | 02/17/2026 | None |
30 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Bionano Genomics, Inc. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other laboratory analytical instruments
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Agilent Technologies, Inc.A | Santa Clara, CA | $6.95B | $1.3B |
| Avantor, Inc.AVTR | Radnor, PA | $6.55B | -$530.2M |
| Illumina, Inc.ILMN | San Diego, CA | $4.34B | $850M |
| Mettler Toledo International Inc/MTD | Columbus, OH | $4.03B | $869.2M |
| Bruker CorpBRKR | Billerica, MA | $3.44B | -$8.6M |
| Waters CorpWAT | Milford, MA | $3.17B | $642.6M |
| Revvity, Inc.RVTY | Waltham, MA | $2.86B | $241.2M |
| Bio-Rad Laboratories, Inc.BIO | Hercules, CA | $2.58B | $759.9M |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Bionano Genomics, Inc.'s CIK number?
- Bionano Genomics, Inc.'s SEC Central Index Key (CIK) is 1411690.
- What is Bionano Genomics, Inc.'s stock ticker?
- Bionano Genomics, Inc. trades as Nasdaq: BNGO.
- What was Bionano Genomics, Inc.'s revenue?
- Bionano Genomics, Inc. reported revenue of $28.51M for the fiscal year ended Dec 31, 2025, -7.4% from the year before.
- When does Bionano Genomics, Inc.'s fiscal year end?
- Bionano Genomics, Inc.'s fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is Bionano Genomics, Inc. headquartered?
- Bionano Genomics, Inc.'s principal executive office on file with the SEC is in San Diego, CA.
- What companies does Bionano Genomics, Inc. own?
- Bionano Genomics, Inc. lists 4 subsidiaries in its SEC filings and other public records, including BioDiscovery, Inc , a California limited liability company, Bionano Genomics (Shanghai) Trading Co., Ltd., Bionano Genomics UK, Ltd.
- Does Bionano Genomics, Inc. sponsor H-1B visas?
- Department of Labor records show 0 certified H-1B filings and 1 certified PERM filings under the name Bionano Genomics, Inc.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026